163 related articles for article (PubMed ID: 25130003)
21. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Angarita FA; Rodríguez JL; Meek E; Sánchez JO; Tawil M; Torregrosa L
World J Surg Oncol; 2013 Jun; 11():128. PubMed ID: 23734899
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer.
Farris A; Bisail M; Sarobba MG; Sanna G; Scotto T; Valzelli S; Intini C
J Chemother; 1993 Oct; 5(5):344-7. PubMed ID: 8106908
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
24. Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report.
Kuranishi F; Ohno T
World J Surg Oncol; 2013 Jun; 11():127. PubMed ID: 23734861
[TBL] [Abstract][Full Text] [Related]
25. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
26. Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
Casadio M; Lelli G; Giordani S; Boltri B; Blotta A; Busutti L; Ramini R; Falcone F; Pannuti F
J Chemother; 1990 Jun; 2(3):199-202. PubMed ID: 2166145
[TBL] [Abstract][Full Text] [Related]
27. Case 3: infiltrating ductal breast carcinoma.
Peoples GE; Arciero C; Adair C; Shriver CD;
Oncology (Williston Park); 2004 Apr; 18(4):437-8, 440. PubMed ID: 15134352
[No Abstract] [Full Text] [Related]
28. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
29. [A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy].
Uchida N; Ishiguro K; Suda T; Nishimura M
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2619-22. PubMed ID: 20009466
[TBL] [Abstract][Full Text] [Related]
30. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
Marks LB; Halperin EC; Prosnitz LR; Ross M; Vredenburgh JJ; Rosner GL; Peters W
Int J Radiat Oncol Biol Phys; 1992; 23(5):1021-6. PubMed ID: 1639635
[TBL] [Abstract][Full Text] [Related]
31. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Ung O; Langlands AO; Barraclough B; Boyages J
J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606
[TBL] [Abstract][Full Text] [Related]
32. Young breast cancer: A single center experience.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
Indian J Cancer; 2014; 51(4):604-8. PubMed ID: 26842210
[TBL] [Abstract][Full Text] [Related]
33. MRI and conservative treatment of locally advanced breast cancer.
Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
[TBL] [Abstract][Full Text] [Related]
34. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
Mamounas EP; Anderson SJ; Dignam JJ; Bear HD; Julian TB; Geyer CE; Taghian A; Wickerham DL; Wolmark N
J Clin Oncol; 2012 Nov; 30(32):3960-6. PubMed ID: 23032615
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
Chang TC; Lai CH; Tseng CJ; Hsueh S; Huang KG; Chou HH
Cancer; 1998 Aug; 83(4):712-8. PubMed ID: 9708935
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of pregnancy associated breast cancer].
Székely B; Langmár Z; Somlai K; Szentmártoni G; Szalay K; Korompay A; Szász AM; Kulka J; Bánhidy F; Dank M
Orv Hetil; 2010 Aug; 151(32):1299-303. PubMed ID: 20656670
[TBL] [Abstract][Full Text] [Related]
37. Comparison of local recurrence and distant metastases between breast cancer patients after postmastectomy radiotherapy with and without immediate TRAM flap reconstruction.
Huang CJ; Hou MF; Lin SD; Chuang HY; Huang MY; Fu OY; Lian SL
Plast Reconstr Surg; 2006 Oct; 118(5):1079-1086. PubMed ID: 17016170
[TBL] [Abstract][Full Text] [Related]
38. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
[TBL] [Abstract][Full Text] [Related]
39. Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancer.
Wörmann B; Meden H; Riggert J; Humpe A; Wulf G; Koch B; Köhler M; Kuhn W; Hiddemann W
Anticancer Res; 1998; 18(3C):2237-41. PubMed ID: 9703793
[TBL] [Abstract][Full Text] [Related]
40. Long term results of surgery and chemotherapy in small cell lung cancer.
Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
